Retrospective Study of Dupilumab Treatment for Moderate to Severe Atopic Dermatitis in Korea: Efficacy and Safety of Dupilumab in Real-World Practice

Among biological agents for the treatment of atopic dermatitis (AD), dupilumab is a front-runner. Although many studies have been conducted on the real-world use of dupilumab, the sample size is often small and data is primarily on Western people. Therefore, we investigated the efficacy and safety o...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Dong Hyek, Heo, Seok Jae, Jung, Hye Jung, Park, Mi Yeon, Seo, Seong Jun, Ahn, Jiyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355558/
https://www.ncbi.nlm.nih.gov/pubmed/32599878
http://dx.doi.org/10.3390/jcm9061982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355558/
https://www.ncbi.nlm.nih.gov/pubmed/32599878
http://dx.doi.org/10.3390/jcm9061982

Ejemplares similares